Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
SERA PROGNOSTICS, INC.
| Metric | SERA PROGNOSTICS, INC. SERAHealthcare |
|---|---|
| Quality Score | 62 / 100 |
| Revenue (latest) | $81,000 |
| Net income (latest) | −$32M |
| Operating margin | −45066.7% |
| Net margin | −39417.3% |
| Return on equity | −42.3% |
| Return on assets | −31.3% |
| Return on capital (ROCE) | −47.0% |
| Debt / equity | 0.35× |
| Revenue growth (YoY) | 5.2% |
| Altman Z″ (distress) | -8.32 |
| Accruals / assets | −6.2% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.